GlaxoSmithKline restless legs drug to run short on CMO issues; Baxter sees Q1 earnings drop on buyout costs;

@FiercePharma: Baxter to put $300M into old Genmab plant in Minnesota. More | Follow @FiercePharma

@EricPFierce: Is your company among the top 10 pharma companies by employees? If so, where does it fall? Story | Follow @EricPFierce

> Production problems at a contract manufacturer will put GlaxoSmithKline's ($GSK) restless legs drug Horizant in short supply till June. Report

> Baxter International's ($BAX) first-quarter earnings dropped on acquisition costs to $552 million, as its pharma-partnering sales suffered. Release | Report

> South Africa's Aspen Pharmacare plans to buy Nestle's nutrition business in the country for $215 million. Report

> Elan ($ELN) bought back $1 billion of its shares at $11.25 each, automatically depressing Royalty Pharma's $7.3 billion takeover offer. Report

> The GAVI Alliance made a deal with India's Biological E to supply a pentavalent childhood vaccine at a price of $1.19 per dose, almost $1-per-shot lower than the weighted average price last year. Report

Medical Device News

@FierceMedDev: Combat Medical Systems wins $86M govt. contract. Story | Follow @FierceMedDev

@MarkHFierce: Dx development for the developing world is a hot new area, and the U.K.'s Lumora is diving in. More | Follow @MarkHFierce

 @DamianFierce:  Abbott won FDA approval for a new eye implant, part of its efforts to boost sluggish medical device sales. News | Follow @DamianFierce

> EU faulty implant trial gets colorful amid patients' jeers. Story

> Illumina reaches into China with diagnostics partnership. Item

> Baxter infusion pump, dialysis sales rise slowly. More

Biotech News

@FierceBiotech: GlaxoSmithKline picks up FDA panel plug for Breo approval. Story | Follow @FierceBiotech

@RyanMFierce: S. Korean biotech Celltrion "drops" late-stage Rituxan biosim. Can you imagine this happening w/ a s. molecule? Nope. Report | Follow @RyanMFierce

> Abbott aids biotech Epizyme in matching epigenetic drug with cancer patients. More

> Roche sees another Rituxan biosimilar trial bite the dust. Article

> Antibiotics upstart Allecra snags €15M VC round amid superbug scare. More

Vaccines News

> H7N9 cases jump, some show resistance to Roche's Tamiflu. More

> Polio eradication push nearing endgame again. Story

> ITS eyes Big Pharma suitors as universal flu vaccine advances. Article

> India's Biological E pentavalent vaccine takes on GSK, J&J. Item

> Vaccine campaign struggling to contain measles outbreak. More

Pharma Manufacturing News

> Issues with contractor leads to shortage of GSK's Horizant. More

> Sanofi expands in Morocco with €20M hub. News

> Canada's Pharmascience opens new distribution center. Story

> Hikma will keep injectables manufacturing. More

> Contaminated capsules dissolve Biostar earnings. Article

And Finally... Fame and achievement in performance-related careers may be earned at the cost of a shorter life, a study found. Report

Suggested Articles

The CD19 antibody, used in tandem with Celgene's Revlimid, represents the first FDA approval in second-line diffuse large B-cell lymphoma.

Sanofi has faced a probe into birth defects tied to seizure med Depakine for years. Now, the investigation is moving forward on manslaughter charges.

Pfizer launched a multichannel awareness campaign centered on a first-ever radio station dedicated solely to metastatic breast cancer.